CYTOMX THERAPEUTICS I
1.0000
07-نوفمبر-24 14:59:50
15 متأخرة بدقائق
الأسهم
0.0000
0.00%
نطاق اليوم
0.9882 - 1.0800
ISIN
N/A
المصدر
NASDAQ
-
17 نوفمبر 2022 06:00:00 بحسب Nasdaq GlobeNewswire
-
CytomX Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
08 نوفمبر 2022 15:10:00 بحسب Nasdaq GlobeNewswire
-
07 نوفمبر 2022 15:15:00 بحسب Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at Upcoming November Investor Conferences
02 نوفمبر 2022 15:15:01 بحسب Nasdaq GlobeNewswire
-
CytomX Therapeutics to Report Third Quarter 2022 Financial Results on November 8, 2022
01 نوفمبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces Phase 1 Data Update for anti-CTLA-4 Probody® Therapeutic BMS-986249
12 سبتمبر 2022 07:00:02 بحسب Nasdaq GlobeNewswire
-
07 سبتمبر 2022 17:05:00 بحسب Nasdaq GlobeNewswire
-
CytomX Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
04 أغسطس 2022 15:15:00 بحسب Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at Upcoming Virtual August Investor Conferences
03 أغسطس 2022 07:00:02 بحسب Nasdaq GlobeNewswire
-
CytomX Therapeutics to Report Second Quarter 2022 Financial Results on August 4, 2022
28 يوليو 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
CytomX Therapeutics Provides Strategic Update
13 يوليو 2022 15:05:00 بحسب Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces Phase 2 Results for Praluzatamab Ravtansine in Breast Cancer
06 يوليو 2022 15:05:00 بحسب Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces New Employment Inducement Grants
16 يونيو 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at Jefferies 2022 Global Healthcare Conference
01 يونيو 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
26 مايو 2022 07:00:00 بحسب Nasdaq GlobeNewswire
-
CytomX Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
05 مايو 2022 15:15:00 بحسب Nasdaq GlobeNewswire
-
CytomX Therapeutics to Report First Quarter 2022 Financial Results on May 5, 2022
28 أبريل 2022 07:00:02 بحسب Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces Retirement of John A. Scarlett, M.D. from Board of Directors
14 أبريل 2022 15:15:00 بحسب Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces Retirement of Frederick W. Gluck from Board of Directors
23 مارس 2022 15:15:00 بحسب Nasdaq GlobeNewswire
-
17 مارس 2022 07:00:01 بحسب Nasdaq GlobeNewswire